Clinical Study of Camrelizumab Combined With TCb Versus TCb in Neoadjuvant Treatment of Triple-negative Breast Cancer
Clinical trial NCT05475678 · RECRUITING
Trial details
- NCT number
- NCT05475678
- Sponsor
- Zhenzhen Liu
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-20
- Primary completion
- 2025-05-31
- Enrollment
- 369
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.